Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

National Cancer Institute (NCI) · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
multiple-myelomarenal-insufficiency
refractory multiple myeloma, c-met inhibitor arq-197, tivantinib, multiple myeloma, plasma cell proliferative disorder, hypercalcemia, hematologic malignancy, plasma cell dyscrasia, cast nephropathy, amyloidosis, osteolysis, renal insufficiency
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 833357
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.